Several state and federal efforts to reduce prescription drug costs have proposed using the Department of Veterans Affairs (VA) as a model, given its ability to obtain deep discounts on medications through direct negotiation with pharmaceutical manufacturers and the use of a national formulary. Published studies using data from a decade ago estimated that Medicare Part D could save $14 billion to $22 billion annually if it paid prices similar to those paid by the VA,1-3 and a recent congressional report4 for 20 brand-name drugs estimated potential annual savings of $2 billion. However, none of these estimates used actual prices paid by the VA, which can be lower than published federal prices. Thus, we used the most recent national data available from Medicare and the VA to quantify the savings Medicare Part D would achieve if it paid the same prices for prescription drugs currently paid by the VA.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Venker B, Stephenson KB, Gellad WF. Assessment of Spending in Medicare Part D If Medication Prices From the Department of Veterans Affairs Were Used. JAMA Intern Med. 2019;179(3):431–433. doi:10.1001/jamainternmed.2018.5874
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: